“The pharmacological profile of SGLT2 inhibitors: Focus on mechanistic aspects and pharmacogenomics”
Prabhsimran Kaur, Bidwan Sekhar Behera, Sandeep Singh, Anjana Munshi
Topics & Concepts
EmpagliflozinMedicineDapagliflozinCanagliflozinPharmacologyHypoglycemiaGlycosuriaPharmacogenomicsPharmacodynamicsDiabetes mellitusType 2 diabetesInsulinPharmacokineticsAdverse effectInternal medicineEndocrinologyDiabetes Treatment and ManagementPancreatic function and diabetesDrug Transport and Resistance Mechanisms